Evolving therapies for the treatment of viral hepatitis

F. F. Poordad, R. G. Gish

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Viral hepatitis refers to a spectrum of diseases caused by one of eight identified hepatotropic viruses that affect humans. The most important, in terms of morbidity and cost to healthcare systems, are hepatitis B and C, which collectively affect over 500 m people worldwide. Causes of morbidity and mortality relate to cirrhosis, disability, portal hypertension and its complications, as well as hepatocellular carcinoma, one of the most common somatic malignancies worldwide. Historically, interferon (IFN) has been the only treatment available to treat chronic viral hepatitis, but there are several other potentially effective alternatives on the horizon.

Original languageEnglish (US)
Pages (from-to)15-34
Number of pages20
JournalEmerging Drugs
Volume4
DOIs
StatePublished - Jan 1 1999
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Evolving therapies for the treatment of viral hepatitis'. Together they form a unique fingerprint.

Cite this